Startups
While Allergan and AbbVie prepare to complete their $63 billion merger later this year, plans are being laid out for a new, stand-alone company called Allergan Aesthetics that will include Botox as a tent pole.
Auris Medical Holding Ltd. announced the formation of a new subsidiary, Zilentin Ltd., to bundle its development projects for the treatment of tinnitus and hearing loss in a separate entity.
Sumitovant will run as a wholly owned subsidiary of Sumitomo Dainippon Pharma.
The Sartorius AI Lab (SAIL) conducts research in the use of artificial intelligence in Sartorius platform solutions for the biopharmaceutical industry
TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, has today announced its corporate name change to SPT Labtech effective from January 6, 2020.
The new company, based in Cambridge, Mass., launched with a platform that “digitizes and quantifies cellular behaviors” in order to understand the dynamics that govern those behaviors.
IFM Therapeutics is launching its third subsidiary this year with a focus on developing next-generation small molecule immunotherapies for inflammatory diseases and cancers.
FerGene, a Ferring subsidiary, was created to commercialize the drug in the U.S. and advance global development.
Kayentis, a global provider of eCOA solutions for clinical trials, announces the opening of a subsidiary in Japan, the world’s third largest pharmaceutical market, where clinical developments have been expanding.
In recognition of consistent year-over-year increases in business and to signal its ongoing commitment to, and investment in, its Healthcare Practice, Kaiser Associates is pleased to announce the launch of Kx Advisors.
PRESS RELEASES